S100A11, a dual growth regulator of epidermal keratinocytes

Amino Acids

Volumn 41, Issue 4, 2011, Pages 797-807

  Sakaguchi, Masakiyo ^a   Huh, Nam Ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Ca2+; Cancer; Cell growth; EF hand; EGF; Epithelial cell; P21 WAF1; RAGE; S100 protein; Skin; TGF

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CALCIUM ION; CYTOSOLIC PHOSPHOLIPASE A2; EPIDERMAL GROWTH FACTOR; LIPOCORTIN 1; PROTEIN S 100; PROTEIN S 100A11; SMAD PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ENZYME ACTIVITY; ENZYME SYNTHESIS; EPIDERMIS; EPITHELIUM CELL; GROWTH INHIBITION; GROWTH STIMULATION; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANNEXIN A1; CELL PROLIFERATION; CYTOPLASM; EPIDERMAL GROWTH FACTOR; EPIDERMIS; GROUP IV PHOSPHOLIPASES A2; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; S100 PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 83255166787     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0747-4     Document Type: Review

References (72)

1. Bianchi R, Giambanco I, Arcuri C, Donato R (2003) Subcellular localization of S100A11 (S100C) in LLC-PK1 renal cells: Calciumand protein kinase c-dependent association of S100A11with S100B and vimentin intermediate filaments.Microsc Res Tech 60:639-651
2. Blott EJ, Griffiths GM (2002) Secretory lysosomes. Nat Rev Mol Cell Biol 3:122-131
3. Broome AM, Eckert RL (2004) Microtubule-dependent redistribution of a cytoplasmic cornified envelope precursor. J Invest Dermatol 122:29-38
4. Cecil DL, Terkeltaub R (2008) Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J Immunol 180:8378-8385
5. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R (2005) Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175:8296-8302
6. Cecil DL, Appleton CT, Polewski MD, Mort JS, Schmidt AM, Bendele A, Beier F, Terkeltaub R (2009) The pattern recognition receptor CD36 is a chondrocyte hypertrophy marker associated with suppression of catabolic responses and promotion of repair responses to inflammatory stimuli. J Immunol 182:5024-5031
7. Chen X, Yeung TK, Wang Z (2000) Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3. Biochem Biophys Res Commun 277:757-763
8. Danielsen EM, van Deurs B, Hansen GH (2003) ''Nonclassical'' secretion of annexin A2 to the lumenal side of the enterocyte brush border membrane. Biochemistry 42:14670-14676
9. Dempsey AC, Walsh MP, Shaw GS (2003) Unmasking the annexin I interaction from the structure of Apo-S100A11. Structure 11:887-897
10. Donato R (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7:711-724
11. Garcia R, Franklin RA, McCubrey JA (2006) EGF induces cell motility and multi-drug resistance gene expression in breast cancer cells. Cell Cycle 5:2820-2826
12. Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331-371
13. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M (2008) S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83:1484-1492
14. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901
15. Holt OJ, Gallo F, Griffiths GM (2006) Regulating secretory lysosomes. J Biochem 140:7-12
16. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D et al (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270:25752-25761
17. Horiuchi S, Unno Y, Usui H, Shikata K, Takaki K, Koito W, Sakamoto Y, Nagai R, Makino K, Sasao A, Wada J, Makino H (2005) Pathological roles of advanced glycation end product receptors SR-A and CD36. Ann N Y Acad Sci 1043:671-675
18. Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, Schmidt AM (2008) Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligandstimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem 283:34457-34468
19. Inada H, Naka M, Tanaka T, Davey GE, Heizmann CW (1999) Human S100A11 exhibits differential steady-state RNA levels in various tissues and a distinct subcellular localization. Biochem Biophys Res Commun 263:135-138
20. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S (2002) Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 511:170-174
21. Keller M, Ruegg A, Werner S, Beer HD (2008) Active caspase-1 is a regulator of unconventional protein secretion. Cell 132:818-831
22. Kim KM, Kim DK, Park YM, Kim CK, Na DS (1994) Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 343:251-255
23. Kim S, Ko J, Kim JH, Choi EC, Na DS (2001a) Differential effects of annexins I, II, III, and V on cytosolic phospholipase A2 activity: specific interaction model. FEBS Lett 489:243-248
24. Kim SW, Rhee HJ, Ko J, Kim YJ, Kim HG, Yang JM, Choi EC, Na DS (2001b) Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J Biol Chem 276:15712-15719
25. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM (1999) N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740-31749
26. Kouno T, Mizuguchi M, Sakaguchi M, Makino E, Mori Y, Shinoda H, Aizawa T, Demura M, Huh NH, Kawano K (2008) The structure of S100A11 fragment explains a local structural change induced by phosphorylation. J Pept Sci 14:1129-1138
27. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272:17810-17814
28. Landriscina M, Soldi R, Bagala C, Micucci I, Bellum S, Tarantini F, Prudovsky I, Maciag T (2001) S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro. J Biol Chem 276:22544-22552
29. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282:31317-31331
30. Leclerc E, Fritz G, Vetter SW, Heizmann CW (2009a) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793:993-1007
31. Leclerc E, Sturchler E, Vetter SW, Heizmann CW (2009b) Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease. Rev Neurosci 20:95-110
32. Mailliard WS, Haigler HT, Schlaepfer DD (1996) Calcium-dependent binding of S100C to the N-terminal domain of annexin I. J Biol Chem 271:719-725
33. Mambula SS, Stevenson MA, Ogawa K, Calderwood SK (2007) Mechanisms for Hsp70 secretion: crossing membranes without a leader. Methods 43:168-175
34. Matsunaga H, Ueda H (2006) Evidence for serum-deprivationinduced co-release of FGF-1 and S100A13 from astrocytes. Neurochem Int 49:294-303
35. Matsuzawa Y, Kiuchi Y, Toyomura K, Matsumoto I, Nakamura H, Fujino H, Murayama T, Kawashima T (2009) Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf. J Pharmacol Sci 111:182-192
36. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter CA, Volker U, Kroemer HK (2006) Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 34:524-533
37. Moore BW (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739-744
38. Mori M, Shimada H, Gunji Y, Matsubara H, Hayashi H, Nimura Y, Kato M, Takiguchi M, Ochiai T, Seki N (2004) S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep 11:1287-1293
39. Murzik U, Hemmerich P, Weidtkamp-Peters S, Ulbricht T, Bussen W, Hentschel J, von Eggeling F, Melle C (2008) Rad54B targeting to DNA double-strand break repair sites requires complex formation with S100A11. Mol Biol Cell 19:2926-2935
40. Naka M, Qing ZX, Sasaki T, Kise H, Tawara I, Hamaguchi S, Tanaka T (1994) Purification and characterization of a novel calcium-binding protein, S100C, from porcine heart. Biochim Biophys Acta 1223:348-353
41. Nukui T, Ehama R, Sakaguchi M, Sonegawa H, Katagiri C, Hibino T, Huh NH (2008) S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J Cell Biochem 104:453-464
42. Ohgami N, Nagai R, Ikemoto M, Arai H, Kuniyasu A, Horiuchi S, Nakayama H (2001a) Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem 276:3195-3202
43. Ohgami N, Nagai R, Miyazaki A, Ikemoto M, Arai H, Horiuchi S, Nakayama H (2001b) Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem 276:13348-13355
44. Olsen E, Rasmussen HH, Celis JE (1995) Identification of proteins that are abnormally regulated in differentiated cultured human keratinocytes. Electrophoresis 16:2241-2248
45. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J Biol Chem 275:29244-29256
46. Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Cordone S, Gradini R, Barsotti P, Liu FT, Di Mario U, Pugliese G (2000) Role of galectin-3 as a receptor for advanced glycosylation end products. Kidney Int Suppl 77:S31-S39
47. Prudovsky I, Bagala C, Tarantini F, Mandinova A, Soldi R, Bellum S, Maciag T (2002) The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export. J Cell Biol 158:201-208
48. Prudovsky I, Tarantini F, Landriscina M, Neivandt D, Soldi R, Kirov A, Small D, Kathir KM, Rajalingam D, Kumar TK (2008) Secretion without Golgi. J Cell Biochem 103:1327-1343
49. Rauvala H, Rouhiainen A (2007) RAGE as a receptor of HMGB1 (amphoterin): roles in health and disease. Curr Mol Med 7:725-734
50. Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC (2004) Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum Pathol 35:1385-1391
51. 2+- dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure 8:175-184
52. Rintala-Dempsey AC, Rezvanpour A, Shaw GS (2008) S100-annexin complexes-structural insights. Febs J 275:4956-4966
53. Robinson NA, Lapic S, Welter JF, Eckert RL (1997) S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 272:12035-12046
54. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H, Tanaka T, Yamada H, Namba M (2000) Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 149:1193-1206
55. 2+-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 163:825-835
56. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M, Huh NH (2004) PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164:979-984
57. 2+- and TGFbeta-induced inhibition of growth of normal human keratinocytes. Proc Natl Acad Sci USA 102:13921-13926
58. Sakaguchi M, Murata H, Sonegawa H, Sakaguchi Y, Futami J, Kitazoe M, Yamada H, Huh NH (2007) Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J Biol Chem 282:35679-35686
59. Sakaguchi M, Sonegawa H, Murata H, Kitazoe M, Futami J, Kataoka K, Yamada H, Huh NH (2008) S100A11, an dual mediator for growth regulation of human keratinocytes. Mol Biol Cell 19:78-85
60. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34:357-364
61. Santini MP, Talora C, Seki T, Bolgan L, Dotto GP (2001) Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci USA 98:9575-9580
62. Seemann J, Weber K, Gerke V (1997) Annexin I targets S100C to early endosomes. FEBS Lett 413:185-190
63. Sonegawa H, Nukui T, Li DW, Takaishi M, Sakaguchi M, Huh NH (2007) Involvement of deterioration in S100C/A11-mediated pathway in resistance of human squamous cancer cell lines to TGF beta-induced growth suppression. J Mol Med 85:753-762
64. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360
65. Tamura Y, Adachi H, Osuga J, Ohashi K, Yahagi N, Sekiya M, Okazaki H, Tomita S, Iizuka Y, Shimano H, Nagai R, Kimura S, Tsujimoto M, Ishibashi S (2003) FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J Biol Chem 278:12613-12617
66. Tanaka M, Adzuma K, Iwami M, Yoshimoto K, Monden Y, Itakura M (1995) Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis. Cancer Lett 89:195-200
67. 2+-binding protein from smooth muscle and non-muscle tissues. J Biol Chem 266:18668-18673
68. Tu CL, Oda Y, Komuves L, Bikle DD (2004) The role of the calciumsensing receptor in epidermal differentiation. Cell Calcium 35:265-273
69. Wein S, Fauroux M, Laffitte J, de Nadai P, Guaini C, Pons F, Comera C (2004) Mediation of annexin 1 secretion by a probenecidsensitive ABC-transporter in rat inflamed mucosa. Biochem Pharmacol 67:1195-1202
70. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691
71. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L (2001) Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 50:1495-1504
72. 2+-dependent inhibition of actin-activated myosin ATPase activity by S100C (S100A11), a novel member of the S100 protein family. Biochem Biophys Res Commun 267:77-79